Stomach Neoplasm Clinical Trials

11 recruiting

Frequently Asked Questions

Common questions about Stomach Neoplasm clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 34 trials

Recruiting
Phase 2

A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors

Metastatic Breast CancerBreast NeoplasmsGastroesophageal Junction Adenocarcinoma+7 more
Seagen, a wholly owned subsidiary of Pfizer172 enrolled139 locationsNCT06157892
Recruiting
Not Applicable

Proximal Versus Total Gastrectomy for Locally Advanced Siewert Type II-III Gastroesophageal Junction Cancer

Gastroesophageal-junction CancerStomach NeoplasmsEsophageal Neoplasms
Nurettin Şahin120 enrolled1 locationNCT07482566
Recruiting
Phase 1

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckHER2 Negative Breast Neoplasms+9 more
Seagen, a wholly owned subsidiary of Pfizer1,006 enrolled154 locationsNCT04389632
Recruiting

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

Stomach NeoplasmsMesotheliomaPancreatic Neoplasms+2 more
National Cancer Institute (NCI)1,000 enrolled1 locationNCT01950572
Recruiting
Phase 1

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

Carcinoma, Non-Small Cell LungGastroesophageal Junction AdenocarcinomaStomach Neoplasms+3 more
Seagen, a wholly owned subsidiary of Pfizer914 enrolled43 locationsNCT06131840
Recruiting
Phase 1

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Breast NeoplasmsCholangiocarcinomaOvarian Neoplasms+4 more
Eli Lilly and Company241 enrolled27 locationsNCT07213791
Recruiting
Phase 1

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

Ovarian NeoplasmsStomach NeoplasmsLung Neoplasms+5 more
National Cancer Institute (NCI)100 enrolled1 locationNCT06885697
Recruiting
Not Applicable

Argon Plasma Coagulation Versus Endoscopic Mucosal Resection for Gastric Adenoma (CLER-GA)

Stomach NeoplasmsPrecancerous ConditionsGastric Adenoma+1 more
Samsung Medical Center160 enrolled3 locationsNCT07161479
Recruiting
Phase 2

Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy

Stomach Neoplasms
Shandong Tumor Hospital66 enrolled1 locationNCT07309185
Recruiting
Phase 2

Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction

Stomach NeoplasmsImmune Checkpoint Inhibitors
Xijing Hospital116 enrolled4 locationsNCT06576921
Recruiting
Phase 2

Perioperative Therapies in Locally Advanced Unresectable Gastric Cancer

Stomach Neoplasms
Jeeyun Lee50 enrolled1 locationNCT06630130
Recruiting
Phase 1Phase 2

Trastuzumab Deruxtecan(T-DXd) and Afatinib Combination in HER2-low Advanced Gastric Cancer

Stomach Neoplasm
Jeeyun Lee61 enrolled1 locationNCT06085755
Recruiting
Phase 1Phase 2

Lenvatinib in Combination With Nivolumab Plus Chemotherapy in Metastatic Gastric Cancer Patients With Malignant Ascites

Gastric CancerGastric Cancer Adenocarcinoma MetastaticStomach Neoplasm
Asan Medical Center61 enrolled1 locationNCT07149090
Recruiting

Comparation of Endoscopic Biopsy and Postoperative Specimen for the Molecular Diagnosis of Gastric Cancer

Stomach NeoplasmsPathologyEndoscopy+1 more
Fudan University510 enrolled1 locationNCT04809025
Recruiting
Not Applicable

Multicenter Study on Laparoscopic Total Gastrectomy for Advanced Gastric Cancer

Stomach Neoplasms
Shanghai Zhongshan Hospital1,018 enrolled1 locationNCT04710758
Recruiting
Not Applicable

Omentum Preservation Versus Complete Omentectomy in Gastrectomy for Gastric Cancer

Stomach Neoplasm
Amsterdam UMC654 enrolled16 locationsNCT05180864
Recruiting
Phase 2Phase 3

[18F]F-FAPI PET/CT and Laparoscopy in Staging Advanced Gastric Cancer

Gastric CancerLocally Advanced Gastric AdenocarcinomaPET/CT+1 more
Leiden University Medical Center250 enrolled10 locationsNCT07018661
Recruiting
Phase 1Phase 2

A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locally Advanced Gastric Cancer

Gastric (Stomach) CancerStomach Neoplasm
Asan Medical Center57 enrolled2 locationsNCT06732856
Recruiting

Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques

Ovarian NeoplasmsStomach NeoplasmsLung Neoplasms+5 more
Yonsei University1,200 enrolled1 locationNCT07035587
Recruiting
Phase 1Phase 2

HTL0039732 in Participants With Advanced Solid Tumours

SarcomaUrinary Bladder NeoplasmsUterine Cervical Neoplasms+11 more
Cancer Research UK150 enrolled5 locationsNCT05944237